These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35691853)

  • 1. Effect of Initial Anticoagulation Targets on Bleeding and Thrombotic Complications for Patients With Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.
    Cercone JL; Kram SJ; Trammel MA; Rackley CR; Lee HJ; Merchant J; Kram BL
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3561-3569. PubMed ID: 35691853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of early perioperative heparin-free anticoagulation for extracorporeal membrane oxygenation on bleeding and thrombotic events in lung transplantation: a retrospective cohort study.
    Qi Z; Gu S; Yu X; Zhang Z; Cui X; Li C; Li M; Zhan Q
    Ther Adv Respir Dis; 2024; 18():17534666241273012. PubMed ID: 39161257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
    Fitousis K; Klasek R; Mason PE; Masud F
    Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood conservation in extracorporeal membrane oxygenation for acute respiratory distress syndrome.
    Agerstrand CL; Burkart KM; Abrams DC; Bacchetta MD; Brodie D
    Ann Thorac Surg; 2015 Feb; 99(2):590-5. PubMed ID: 25499483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
    Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
    J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.
    Martucci G; Panarello G; Occhipinti G; Ferrazza V; Tuzzolino F; Bellavia D; Sanfilippo F; Santonocito C; Bertani A; Vitulo P; Pilato M; Arcadipane A
    J Intensive Care Med; 2019 Aug; 34(8):630-639. PubMed ID: 28460592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
    Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
    Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
    Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
    Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
    Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
    Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
    Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
    Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
    Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
    Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
    Martucci G; Giani M; Schmidt M; Tanaka K; Tabatabai A; Tuzzolino F; Agerstrand C; Riera J; Ramanan R; Grasselli G; Ait Hssain A; Gannon WD; Buabbas S; Gorjup V; Trethowan B; Rizzo M; Fanelli V; Jeon K; De Pascale G; Combes A; Ranieri MV; Duburcq T; Foti G; Chico JI; Balik M; Broman LM; Schellongowski P; Buscher H; Lorusso R; Brodie D; Arcadipane A;
    Am J Respir Crit Care Med; 2024 Feb; 209(4):417-426. PubMed ID: 37943110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.